Bourgeon Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-137,535
Closed -$11M 122
2024
Q4
$11M Sell
137,535
-1,897
-1% -$164K 2.05% 18
2024
Q3
$12.6M Sell
139,432
-2,429
-2% -$204K 2.41% 13
2024
Q2
$11.2M Buy
141,861
+724
+0.5% +$59.4K 2.19% 17
2024
Q1
$12.3M Buy
141,137
+968
+0.7% +$82.6K 2.41% 13
2023
Q4
$11.5M Sell
140,169
-477
-0.3% -$36.4K 2.55% 10
2023
Q3
$11M Sell
140,646
-1,507
-1% -$126K 2.59% 10
2023
Q2
$12.5M Buy
142,153
+1,102
+0.8% +$94.9K 2.92% 8
2023
Q1
$11.4M Buy
141,051
+4,031
+3% +$329K 2.71% 10
2022
Q4
$10.6M Buy
137,020
+229
+0.2% +$18.6K 2.61% 13
2022
Q3
$11M Buy
136,791
+1,642
+1% +$148K 3.04% 8
2022
Q2
$12.1M Sell
135,149
-557
-0.4% -$56.4K 3.21% 6
2022
Q1
$15.1M Buy
135,706
+54,694
+68% +$5.78M 3.41% 3
2021
Q4
$8.38M Sell
81,012
-30,348
-27% -$3.51M 1.73% 22
2021
Q3
$14M Sell
111,360
-537
-0.5% -$69.5K 2.98% 7
2021
Q2
$13.9M Buy
111,897
+7,020
+7% +$881K 2.99% 7
2021
Q1
$12.4M Buy
104,877
+25,815
+33% +$3.03M 2.75% 6
2020
Q4
$9.26M Sell
79,062
-233
-0.3% -$25.6K 2.29% 17
2020
Q3
$8.24M Buy
+79,295
New +$7.96M 2.5% 16

Other funds holding MDT

Bourgeon Capital Management's MDT Position: Q1 2025 in Review

Bourgeon Capital Management sold out of Medtronic (MDT) in Q1 2025, closing a stake of 137,535 shares — an estimated $11M sold.

Bourgeon Capital Management first reported a position in MDT in Q3 2020 and held it in 18 quarters. The position peaked at $15.1M in Q1 2022. 2,171 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Bourgeon Capital Management reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • Bourgeon Capital Management sold 137,535 Medtronic shares in Q1 2025, an estimated $11M.
  • Bourgeon Capital Management first reported a position in Medtronic in Q3 2020 and held it in 18 quarters.
  • Bourgeon Capital Management's Medtronic position peaked at $15.1M in Q1 2022.
  • 2,171 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Bourgeon Capital Management's 13F filing for Q1 2025, filed 9 Apr 2025.